Evaluations and CME Certificates

2022 evaluations will be available on the first day of the meeting. Please email evals@HealioLive.com if you need assistance with this year’s credits or cme@VindicoMedEd.com if you need a certificate from a previous year.

Target Audience

The intended audience for this activity is comprehensive ophthalmologists and other health care professionals involved in the management of patients with ophthalmic disorders and related health conditions.

Learning Objectives: General Sessions

Upon successful completion of this activity, participants should be better able to:

  • Compare the efficacy of conventional and new diagnostic modalities, as well as delivery systems, being used in the clinical and surgical ophthalmology practice.
  • Examine complex cataract IOL and refractive cases via video presentations and how comprehensive ophthalmologists can effectively manage these patients.
  • Evaluate new surgical techniques in various ophthalmic subspecialties and conditions.
  • Examine the latest technological advances in cataract surgery, lens and patient selection, as well as preoperative and postoperative strategies.
  • Describe the latest medical, laser, and surgical advances in glaucoma treatment and management.
  • Evaluate various corneal conditions and diseases, as well as medical and surgical procedures that have been shown to effectively treat these disorders.
  • Evaluate retinal disease, medical and surgical advances, and pertinent clinical trial data to better understand what is essential for a comprehensive ophthalmologist to know to improve patient outcomes.
  • Summarize new information pertaining to the use of oculoplastics in the comprehensive ophthalmology practice.
  • Examine how practice management services and approaches integrated into the daily office flow can better serve patients.

Learning Objectives: Friday CME Seminar

Upon successful completion of this activity, participants should be better able to:

  • Recognize injectables that lengthen dosing intervals in the treatment of nAMD or DME.
  • Describe new and emerging surgical therapies that can reduce reliance on frequent anti-vascualr endothelial growth factor (VEGF) injections in patients with nAMD or DME.

Learning Objectives: Saturday CME Seminar

Upon successful completion of this activity, participants should be better able to:

  • Review the pathophysiology, risk factors, symptoms, and nomenclature associated with thyroid eye disease.
  • Evaluate tools and testing that can detect and differentiate phases of thyroid eye disease, as well as ensure that the thyroid abnormality is controlled.
  • Differentiate currently available thyroid eye disease treatments based on their efficacy, safety, and ability to improve the overall management of the condition.
This continuing medical education activity is jointly provided by
Vindico Medical Education

Kiawah Eye 2022 is supported, in part, by independent medical education grants from Carl Zeiss Meditec, Inc.; Genentech, a member of the Roche Group; Horizon Therapeutics USA, Inc.; and Regeneron Pharmaceuticals, Inc.

ACCREDITATION: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Vindico Medical Education and MUSC Storm Eye Institute. Vindico Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION: Vindico Medical Education designates this live activity for a maximum of 17.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

FACULTY/PLANNER DISCLOSURE POLICY: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of accredited content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be mitigated and disclosed to the activity audience.

NOTICE: Faculty, topics, program schedule, and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program director and the Office of Medical Affairs and Compliance.